ReviewFrontiers in neurology2022

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies.

Sindhu Menon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.